N-acetyl-l-cysteine is reported to counteract the oxygen-free radical effects25,26 and improve antitumor response of interferon alpha by NF-κB downregulation in HepG2 and Huh7 liver cancer cells. The gene discussed is NFKB1; the disease is liver cancer.